Daiwa Securities Group Inc. grew its position in Thermo Fisher Scientific Inc (NYSE:TMO) by 1.4% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 11,250 shares of the medical research company’s stock after acquiring an additional 150 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Thermo Fisher Scientific were worth $1,963,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. BB&T Securities LLC lifted its position in shares of Thermo Fisher Scientific by 4.4% during the 1st quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock worth $13,798,000 after buying an additional 3,819 shares during the period. Toronto Dominion Bank lifted its position in shares of Thermo Fisher Scientific by 53.5% during the 1st quarter. Toronto Dominion Bank now owns 107,099 shares of the medical research company’s stock worth $16,450,000 after buying an additional 37,307 shares during the period. IBM Retirement Fund lifted its position in shares of Thermo Fisher Scientific by 117.7% during the 2nd quarter. IBM Retirement Fund now owns 9,537 shares of the medical research company’s stock worth $1,860,000 after buying an additional 5,157 shares during the period. Advisors Asset Management Inc. lifted its position in shares of Thermo Fisher Scientific by 1.1% during the 1st quarter. Advisors Asset Management Inc. now owns 66,308 shares of the medical research company’s stock worth $10,185,000 after buying an additional 735 shares during the period. Finally, Cornerstone Investment Partners LLC lifted its position in shares of Thermo Fisher Scientific by 41.7% during the 2nd quarter. Cornerstone Investment Partners LLC now owns 421,541 shares of the medical research company’s stock worth $73,546,000 after buying an additional 123,954 shares during the period. Institutional investors own 83.52% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Daiwa Securities Group Inc. Increases Holdings in Thermo Fisher Scientific Inc (TMO)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/09/11/daiwa-securities-group-inc-increases-holdings-in-thermo-fisher-scientific-inc-tmo.html.

Several equities analysts recently commented on the company. Cowen and Company restated a “buy” rating on shares of Thermo Fisher Scientific in a research report on Sunday. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 target price for the company in a research report on Thursday. Morgan Stanley restated an “overweight” rating and set a $220.00 target price on shares of Thermo Fisher Scientific in a research report on Wednesday, September 6th. Bank of America Corporation restated a “buy” rating and set a $210.00 target price (up previously from $200.00) on shares of Thermo Fisher Scientific in a research report on Friday, July 21st. Finally, Barclays PLC restated an “overweight” rating and set a $200.00 target price (up previously from $190.00) on shares of Thermo Fisher Scientific in a research report on Monday, July 17th. One equities research analyst has rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus target price of $191.94.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) opened at 191.63 on Monday. Thermo Fisher Scientific Inc has a 1-year low of $139.07 and a 1-year high of $192.28. The firm has a market capitalization of $74.76 billion, a PE ratio of 33.39 and a beta of 1.05. The stock has a 50 day moving average price of $178.31 and a 200 day moving average price of $169.32.

Thermo Fisher Scientific (NYSE:TMO) last announced its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, beating the Zacks’ consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a return on equity of 15.97% and a net margin of 11.80%. The company had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.92 billion. During the same period in the prior year, the company earned $2.03 EPS. Thermo Fisher Scientific’s revenue was up 10.2% compared to the same quarter last year. Equities research analysts anticipate that Thermo Fisher Scientific Inc will post $9.35 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be paid a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.31%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s payout ratio is 10.45%.

In other news, VP Peter E. Hornstra sold 3,894 shares of the stock in a transaction on Tuesday, September 5th. The stock was sold at an average price of $185.18, for a total value of $721,090.92. Following the completion of the transaction, the vice president now directly owns 19,751 shares in the company, valued at approximately $3,657,490.18. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Jim P. Manzi sold 1,000 shares of the stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $175.20, for a total value of $175,200.00. Following the completion of the transaction, the director now owns 38,757 shares of the company’s stock, valued at $6,790,226.40. The disclosure for this sale can be found here. Insiders sold a total of 22,738 shares of company stock valued at $4,021,512 over the last quarter. 0.49% of the stock is owned by corporate insiders.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.